STOCK TITAN

Inovio Pharmaceuticals, Inc. (INO) Revenue by Year

INO

Inovio Pharmaceuticals, Inc. generated $65K in revenue in fiscal year 2025. This represents a decrease of 70.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Inovio Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $65K
YoY -70.0%
5Y CAGR -61.2%
10Y CAGR -47.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INO Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$65K-70.0%$218K-73.8%$832K-91.9%$10.3M+478.2%$1.8M-76.1%$7.4M+80.2%$4.1M-86.5%$30.5M-27.8%$42.2M+19.4%$35.4M-12.8%$40.6M+288.0%$10.5M-22.4%$13.5M+227.0%$4.1M-58.0%$9.8M

INO Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$0n/m$0-100.0%N/A$0n/m$0-100.0%$65Kn/mN/A$0-100.0%$101K-55.4%$0-100.0%$103K-17.7%$388K-95.8%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Inovio Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Inovio Pharmaceuticals, Inc.'s revenue in fiscal year 2025?

Inovio Pharmaceuticals, Inc. generated $65K in revenue in fiscal year 2025.

How fast is Inovio Pharmaceuticals, Inc.'s revenue growing?

Inovio Pharmaceuticals, Inc. (INO) revenue fell by 70.0% year over year, from $218K to $65K in fiscal year 2025.

How has Inovio Pharmaceuticals, Inc.'s revenue changed over the years?

Across the 15 fiscal years this page covers, Inovio Pharmaceuticals, Inc. (INO) revenue went from $9.8M in fiscal year 2011 to $65K in fiscal year 2025.

Inovio Pharmaceuticals, Inc. (INO) reported $0 in revenue in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Inovio Pharmaceuticals, Inc. (INO) reported on that line in every period on record.